Atrial fibrillation in patients with end‐stage renal disease on hemodialysis: Magnitude of the problem and new approach to oral anticoagulation
Abstract Atrial fibrillation (AF) is a frequent comorbid condition in patients with end‐stage renal disease on hemodialysis (HD) with a prevalence of up to 27%. The incidence rate of stroke in AF patients on HD is approximately 5%. The AF‐associated risk of stroke is a major clinical challenge becau...
Main Authors: | Oliver Königsbrügge, Cihan Ay |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-10-01
|
Series: | Research and Practice in Thrombosis and Haemostasis |
Subjects: | |
Online Access: | https://doi.org/10.1002/rth2.12250 |
Similar Items
-
Management of anticoagulation in atrial fibrillation patients in Italy: insight from the <i>Atrial Fibrillation-Survey on Anticoagulated Patients Register</i> (AF-START)
by: Daniela Poli, et al.
Published: (2023-06-01) -
Oral Anticoagulant Use in Patients with Atrial Fibrillation at Low Risk of Stroke and Associated Bleeding Complications
by: Adane Teshome Kefale, et al.
Published: (2023-09-01) -
Editorial: Effects of oral anticoagulant therapy in atrial fibrillation patients with comorbidities
by: Runkai Li, et al.
Published: (2023-05-01) -
Geographical Variation in the Use of Oral Anticoagulation and Clinical Outcomes among Patients with Atrial Fibrillation in Denmark, Sweden, and Finland
by: Lars Frost, et al.
Published: (2023-04-01) -
New Insights into Anticoagulation in Atrial Fibrillation
by: Xiaohan Fan, MD, et al.
Published: (2011-01-01)